Kenya has set eyes on manufacturing HIV antiretroviral (ARV) drugs for both local and global consumption, pending approval from regulatory bodies.Director General for Health, Patrick Amoth, says the ...

Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...

Central Ohio has undergone a remarkable economic transformation. Columbus and its surrounding areas have attracted ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

CEO John Houston emphasized that Arvinas is nearing key milestones, including the first Phase 3 topline data for vepdegestrant (vepdeg) from the VERITAC-2 trial expected in Q1 2025. He noted that this ...

NEW HAVEN, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ...

Speaking to Daily News over the weekend, Government Chief Spokesperson and Permanent Secretary for the Ministry of ...

Greater Chennai Corporation to conduct mass anti-rabies vaccination drive for stray dogs in Velachery after multiple dog bites.

DODOMA: THE Ministry of Health has dismissed reports circulating on social media about a shortage of antiretroviral ...

wondered how they would cope without life-saving antiretroviral (ARV) therapies. In a time of both misinformation and too much information, quality journalism is more crucial than ever.

"Short-term, I hope that some money can flow so that medium- and long- term, we can make other plans," said Dawie Nel ... people receive anti-retroviral (ARV) treatment, according to the health ...